rs1131690843
Variant summary
Our verdict is Pathogenic. Variant got 12 ACMG points: 12P and 0B. PM2PM5PP5_Very_Strong
The ENST00000267163.6(RB1):c.380G>A(p.Ser127Asn) variant causes a missense, splice region change. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a benign outcome for this variant. 2/3 splice prediction tools predicting alterations to normal splicing. Variant has been reported in ClinVar as Likely pathogenic (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. S127T) has been classified as Likely pathogenic.
Frequency
Consequence
ENST00000267163.6 missense, splice_region
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 12 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
RB1 | NM_000321.3 | c.380G>A | p.Ser127Asn | missense_variant, splice_region_variant | 3/27 | ENST00000267163.6 | NP_000312.2 | |
RB1 | NM_001407165.1 | c.380G>A | p.Ser127Asn | missense_variant, splice_region_variant | 3/27 | NP_001394094.1 | ||
RB1 | NM_001407166.1 | c.380G>A | p.Ser127Asn | missense_variant, splice_region_variant | 3/17 | NP_001394095.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
RB1 | ENST00000267163.6 | c.380G>A | p.Ser127Asn | missense_variant, splice_region_variant | 3/27 | 1 | NM_000321.3 | ENSP00000267163 | P1 | |
RB1 | ENST00000467505.5 | c.138-17303G>A | intron_variant, NMD_transcript_variant | 1 | ENSP00000434702 | |||||
RB1 | ENST00000650461.1 | c.380G>A | p.Ser127Asn | missense_variant, splice_region_variant | 3/27 | ENSP00000497193 | ||||
RB1 | ENST00000525036.1 | n.542G>A | splice_region_variant, non_coding_transcript_exon_variant | 3/7 | 3 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome Data not reliable, filtered out with message: AC0 AF: 0.00 AC: 0AN: 1430450Hom.: 0 Cov.: 26 AF XY: 0.00 AC XY: 0AN XY: 713442
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
Retinoblastoma Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Genetic Diagnostic Laboratory, University of Pennsylvania School of Medicine | May 20, 2024 | Case and Pedigree Information: BILATERAL CASES:2, UNILATERAL CASES:1, TOTAL CASES:3, PEDIGREES:3. ACMG Codes Applied:PVS1, PM2, PS4SUP - |
not provided Pathogenic:1
Likely pathogenic, criteria provided, single submitter | clinical testing | GeneDx | Mar 02, 2020 | Not observed in large population cohorts (Lek 2016); While protein-based in silico analysis supports that this variant does not alter protein structure/function, splice predictors support a deleterious effect; This variant is associated with the following publications: (PMID: 15884040, 25928201) - |
Hereditary cancer-predisposing syndrome Pathogenic:1
Likely pathogenic, criteria provided, single submitter | clinical testing | Ambry Genetics | Mar 04, 2016 | The c.380G>A variant (also known as p.S127N), located in coding exon 3 of the RB1 gene, results from a G to A substitution at nucleotide position 380. The amino acid change results in serine to asparagine at codon 127, an amino acid with highly similar properties. However, this change occurs in the last base pair of coding exon 3, which makes it likely to have some effect on normal mRNA splicing. This variant was reported in an individual with bilateral retinoblastoma, but no family history of the disease. The authors also performed RNA studies, which showed aberrant splicing (Nichols KE et al. Hum. Mutat. 2005 Jun; 25(6):566-74). This variant was not reported in population based cohorts in the following databases: Database of Single Nucleotide Polymorphisms (dbSNP), NHLBI Exome Sequencing Project (ESP), and 1000 Genomes Project. In the ESP, this variant was not observed in 6502 samples (13004 alleles) with coverage at this position. Both the nucleotide and amino acid positions are highly conserved in available vertebrate species. Using the BDGP and ESEfinder splice site prediction tools, this alteration is predicted to weaken the efficiency of the native splice donor site; however, direct experimental evidence is unavailable. In addition, this alteration is predicted to be tolerated by in silico analysis. Based on the majority of available evidence to date, this variant is likely to be pathogenic. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at